Clinical development
- Rwanda To Begin Vaccine Trials For Deadly Maburg Virus
07 Oct, 2024 - Transgene: new data to come on TG4050 vaccine
07 Oct, 2024 - NBM-funded vaccine to ramp up Kerala’s fight against dengue, chikungunya
07 Oct, 2024 - Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals
06 Oct, 2024 - AIM Vaccine Co. Pioneers Serum-Free Rabies Vaccine
06 Oct, 2024 - First Ovarian Cancer Vaccine shows promise for potential eradication
05 Oct, 2024 - Researchers seek participants for trial on combo vaccine for winter viruses
04 Oct, 2024 - Human Papillomavirus (HPV)-induced Cancers: First Patient Enrolled in Phase I/IIa Clinical Trial for Lenti-HPV-07, the TheraVectys’ Therapeutic Vaccine Candidate Against Oropharyngeal and Cervical Cancers
04 Oct, 2024 - Evaluating Safety and Efficacy of Vaxart’s Oral Vaccine’s Impact on COVID-19 Variants
04 Oct, 2024 - Vaxart Initiates Phase 2b Study of Oral COVID-19 Vaccine
03 Oct, 2024 - Phase 2/3 trial of new omicron-targeted vaccine shows efficacy in adolescents
03 Oct, 2024 - First-Line Versamune HPV Vaccine Bolsters Responses With SOC Pembrolizumab in HPV16+ Recurrent HNSCC
03 Oct, 2024 - NIH selects Emergex’s T cell vaccine for trials under Project NextGen
03 Oct, 2024 - FG begins study to facilitate Lassa fever vaccine production
03 Oct, 2024 - Barinthus Bio completes enrolment in hepatitis B and prostate cancer vaccine trials
02 Oct, 2024 - Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine
02 Oct, 2024 - 2 Greater Cleveland auto shop owners help honor memory of first experimental breast cancer vaccine recipient
01 Oct, 2024 - MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine
01 Oct, 2024 - CNS 2024 Conference Presentation: Diakonos Oncology’s Autologous Dendritic Cell Vaccine (DOC1021) Yields 93% 12-Month Survival for Glioblastoma Patients
01 Oct, 2024 - Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
30 Sep, 2024 - Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer’s Comirnaty Shot, Even At Lower Doses
30 Sep, 2024
0 Comments